Monte Rosa Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $474k | 64k | 7.41 |
| 2025-06-30 | $287k | 64k | 4.51 |
| 2025-03-31 | $289k | 62k | 4.64 |
| 2024-12-31 | $429k | 62k | 6.94 |
| 2024-09-30 | $278k | 53k | 5.30 |
| 2024-06-30 | $179k | 48k | 3.74 |
| 2024-03-31 | $328k | 47k | 7.05 |
| 2023-12-31 | $256k | 45k | 5.65 |
| 2023-09-30 | $218k | 46k | 4.79 |
| 2023-06-30 | $308k | 45k | 6.85 |
| 2023-03-31 | $360k | 46k | 7.80 |
| 2022-12-31 | $334k | 44k | 7.62 |
| 2022-09-30 | $351k | 43k | 8.17 |
| 2022-06-30 | $392k | 41k | 9.67 |
| 2022-03-31 | $339k | 24k | 14.01 |
| 2021-09-30 | $206k | 9.2k | 22.31 |